N-Acetyltransferase phenotype of patients with bladder cancer.
N-Acetyltransferase phenotype has been determined in 109 control subjects and in 23 patients with bladder cancer. Sixty-two per cent of control, and 39% of patients with bladder cancer were phenotypically slow acetylators. This difference was not significant. N-Acetyltransferase phenotype is unlikely to be a major determinant in the development of bladder cancer in the Turkish population.
D000123:Acetyltransferases / Q000235:genetics*; D000293:Adolescent; D000328:Adult; D001191:Arylamine N-Acetyltransferase / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D014421:Turkey; D001749:Urinary Bladder Neoplasms / Q000201:enzymology* / Q000235:genetics
D000123:Acetyltransferases; D001191:Arylamine N-Acetyltransferase